09:15 AM EDT, 07/30/2026 (MT Newswires) -- Healthcare stocks were declining premarket Thursday, with the State Street Health Care Select Sector SPDR ETF ( XLV ) down 1.4% and the iShares Biotechnology ETF (IBB) 1.6% lower.

Johnson & Johnson ( JNJ ) said it has entered into strategic agreements with Sail Biomedicines to advance the biotech's in vivo CAR-T therapy platform for immune-mediated diseases, including an equity investment and an exclusive option to acquire Sail for $2.58 billion. Shares of Johnson & Johnson ( JNJ ) were down more than 2% pre-bell.

Bristol-Myers Squibb ( BMY ) stock was down more than 1% even after the company posted higher Q2 non-GAAP earnings and revenue, and raised its 2026 outlook.

Regeneron Pharmaceuticals ( REGN ) shares were up more than 1% after the company reported higher Q2 adjusted earnings and revenue.